DJIA 18,203.37 -85.26 -0.47%
NASDAQ 4,979.90 -28.20 -0.56%
S&P 500 2,107.78 -9.61 -0.45%
market minute promo

4.04 -0.24 (-5.61%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ARNA $4.04 -5.61%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.20
Previous Close $4.28
Daily Range $3.85 - $4.20
52-Week Range $3.26 - $7.24
Market Cap $889.3M
P/E Ratio -15.29
Dividend (Yield) $0.00 (0.0%)
Volume 13,908,920
Average Daily Volume 5,756,285
Current FY EPS -$0.26




Drug Makers

Arena Pharmaceuticals, Inc. (ARNA) Description

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website:

News & Commentary

Why Arena Pharmaceuticals, Inc. Burst Today

Arena Pharmaceuticals shares slumped after reporting lackluster earnings and competitors positive news.

Arena Pharmaceuticals' Q4 Loss Wider than Expected - Analyst Blog

Why Orexigen Therapeutics, Inc. Stock Exploded Higher

Orexigen Therapeutics looks like it has the first game-changing obesity drug on its hands. Here's what you need to know.

Orexigen Weight-Loss Pill Shows Surprise Heart-Safety Benefit

Arena Pharmaceuticals (ARNA) Stock: Weak On High Volume Today

Morning Market Losers

Benzinga's Top #PreMarket Losers

Arena Misses On Earnings: Investors Need To Look Deeper

Arena Pharmaceuticals, Inc. Earnings: Explaining the Wonky Trends

A fourth-quarter slowdown and relatively flat sales over the year.

Arena's (ARNA) CEO Jack Lief on Q4 2014 Results - Earnings Call Transcript

See More ARNA News...

ARNA's Top Competitors

ARNA $4.04 (-5.61%)
Current stock: ARNA
AMGN $158.56 (-0.67%)
Current stock: AMGN
GILD $102.79 (-1.00%)
Current stock: GILD
BIIB $412.79 (-0.72%)
Current stock: BIIB